Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India
New Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo Nordisk, following intense competition from multiple pharmaceutical firms,…